Please Enable Cookies

www.laserfocusworld.com is using a security service for protection against online attacks. This process is automatic. You will be redirected once the validation process is complete.

Coeptis Therapeutics pursuing possible acquisition of cell therapy platform

Coeptis did not offer a timeline as to when it expects to conclude its due diligence analysis, which has since begun.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.